• Users Online: 87
  • Print this page
  • Email this page
Year : 2020  |  Volume : 32  |  Issue : 1  |  Page : 103-106

Unilateral macular choroidal neovascularization; a rare manifestation in chronic myelogenous leukemia

Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran

Correspondence Address:
Hooshang Faghihi
Farabi Eye Hospital, Qazvin Square, South Kargar Street, Tehran 1336616351
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.1016/j.joco.2019.09.003

Rights and Permissions

Purpose: To report a case of chronic myelogenous leukemia (CML) treatment with imatinib mesylate in the remission phase who developed unilateral macular choroidal neovascularization (CNV). Methods: A 45-year-old male marketer with a 5-year history of CML treated with imatinib mesylate presented with 2 months history of progressive vision loss and metamorphopsia in the right eye. Results: Fundus examination of the right eye revealed grey-white elevated retinal lesion with indistinct borders in the macula and retinal telangiectasia in the temporal macula. Fluorescein angiography (FA) and optical coherence tomography angiography (OCTA) confirmed the presence of CNV in the right eye. After treatment with anti-vascular endothelial growth factor (anti-VEGF), macular CNV regressed significantly. Conclusion: Macular CNV must be kept in mind as a rare ophthalmic manifestation of patients with CML under treatment with imatinib even in the remission phase.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded72    
    Comments [Add]    
    Cited by others 1    

Recommend this journal